Sigyn Therapeutics Appoints Eric Lynam as Head of Clinical Affairs
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions […]
Mr. Lynam to Oversee Clinical Studies of Sigyn Therapy™ to Treat Life-Threatening Inflammatory Conditions […]
Eastplats issued 36,841,741 common shares of the Company (each a “Common Share”) at a price of CDN$0.32 per Common Share […]
Vancouver, British Columbia–(Newsfile Corp. – January 22, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTC Pink: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic medicines to treat addiction, is […]
THIS INTERVIEW HAS EXPIRED
Vancouver, British Columbia–(Newsfile Corp. – January 19, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) (OTC Pink: ENTBF) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced […]
During the interview, Mr. Joyce discusses recent data-driven milestones that reinforce the potential for Sigyn Therapy™ to overcome the limitations of previous strategies to treat sepsis and other life-threatening inflammatory conditions. […]
TORONTO – January 19, 2021 − CANAQUEST MEDICAL CORP (OTC Markets: “CANQF”) (the “Company” or “CanaQuest”), a Life Science/Pharmaceutical Company developing health products utilizing cannabinoid molecules and other botanical compounds (pharmaceutical grade), is pleased to release a recent interview with […]
is pleased to announce it has completed an extensive data compilation program resulting in the identification of highly elevated gold, copper and silver occurrences spread across the 8,136 hectare Lucky Mike Silver Lode Project […]
CEO Jim Joyce discusses Sigyn’s recent news over the last couple months which includes a pilot study to address inflammatory CytoVesicles. […]
Mr. Kenney is a long-established influencer and identifier of trends whose ability to reach broad audiences and access some of the top names in the entertainment industry […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com